[ASAP] Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation 🔗 Access full article via ACS Journal of Medicinal ChemistryAI SummaryThe text is missing.Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
